Acerus Pharmaceuticals Corporation

Acerus Pharmaceuticals Corporationverified

ASP.TO

Price:

$0.36

Market Cap:

$2.02M

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina,...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2009-09-03

Stock Exchange

TSX

Ticker

ASP.TO

The ROE as of December 2025 (TTM) for Acerus Pharmaceuticals Corporation (ASP.TO) is 310.28%

According to Acerus Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current ROE is 310.28%. This represents a change of 268.69% compared to the average of 84.16% of the last 4 quarters.

Acerus Pharmaceuticals Corporation (ASP.TO) Historical ROE (quarterly & annually)

How has ASP.TO ROE performed in the past?

The mean historical ROE of Acerus Pharmaceuticals Corporation over the last ten years is 2.53%. The current 310.28% ROE has changed -87.73% with respect to the historical average. Over the past ten years (40 quarters), ASP.TO's ROE was at its highest in in the December 2018 quarter at 7.11%. The ROE was at its lowest in in the September 2020 quarter at -29366.67%.

Quarterly (TTM)
Annual

Average

2.53%

Median

-23.22%

Minimum

-772.91%

Maximum

26.46%

Acerus Pharmaceuticals Corporation (ASP.TO) ROE by Quarter and Year

Discovering the peaks and valleys of Acerus Pharmaceuticals Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 301.61%

Maximum Annual ROE = 26.46%

Minimum Annual Increase = -18063.32%

Minimum Annual ROE = -772.91%

Quarterly (TTM)
Annual
YearROEChange
2021136.30%-117.63%
2020-772.91%-714.87%
2019125.70%-99.52%
201826.46%-18063.32%
2017-147.30%-261.63%
201691.13%-75.19%
2015367.26%-366.97%
2014-137.57%-41.56%
2013-235.40%-60.10%
2012-589.91%301.61%

Acerus Pharmaceuticals Corporation (ASP.TO) Average ROE

How has ASP.TO ROE performed in the past?

The current ROE of Acerus Pharmaceuticals Corporation (ASP.TO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-170.30%

5-year avg

5.16%

10-year avg

2.53%

Acerus Pharmaceuticals Corporation (ASP.TO) ROE vs. Peers

How is ASP.TO’s ROE compared to its peers?

Acerus Pharmaceuticals Corporation’s ROE is less than ManifestSeven Holdings Corporation (1.66%), greater than Craftport Cannabis Corp. (-194.22%), less than Radient Technologies Inc. (0%), less than Flower One Holdings Inc. (444.10%), less than Choom Holdings Inc. (409.02%), less than AREV Life Sciences Global Corp. (276.09%), greater than Isracann Biosciences Inc. (-221.78%), less than Aion Therapeutic Inc. (29.13%), less than Revitalist Lifestyle and Wellness Ltd. (313.56%), greater than North Bud Farms Inc. (-27.00%),

Build a custom stock screener for Acerus Pharmaceuticals Corporation (ASP.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acerus Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acerus Pharmaceuticals Corporation (ASP.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acerus Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Acerus Pharmaceuticals Corporation's ROE?

How is the ROE calculated for Acerus Pharmaceuticals Corporation (ASP.TO)?

What is the highest ROE for Acerus Pharmaceuticals Corporation (ASP.TO)?

What is the 3-year average ROE for Acerus Pharmaceuticals Corporation (ASP.TO)?

What is the 5-year average ROE for Acerus Pharmaceuticals Corporation (ASP.TO)?

How does the current ROE for Acerus Pharmaceuticals Corporation (ASP.TO) compare to its historical average?